CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-16 | EASTHAM KARIN Director | Grant or award | +10,200 | 23,233 | ||
| 2022-09-16 | EASTHAM KARIN Director | Grant or award · Stock Option | +20,400 | 20,400 | ||
| 2022-09-13 | EASTHAM KARIN Director | Sale | −21,267 | $3.61 | $77K | 13,033 |
| 2021-09-22 | EASTHAM KARIN Director | Grant or award | +10,200 | 34,300 | ||
| 2021-09-22 | EASTHAM KARIN Director | Grant or award · Stock Option | +20,400 | 20,400 | ||
| 2020-09-22 | EASTHAM KARIN Director | Grant or award | +9,100 | 24,100 | ||
| 2020-09-22 | EASTHAM KARIN Director | Grant or award · Stock Option | +18,200 | 18,200 | ||
| 2020-09-22 | EASTHAM KARIN Director | Grant or award | +9,100 | 24,100 | ||
| 2020-09-22 | EASTHAM KARIN Director | Grant or award · Stock Option | +18,200 | 18,200 | ||
| 2019-09-25 | EASTHAM KARIN Director | Grant or award | +6,500 | 15,000 | ||
| 2019-09-25 | EASTHAM KARIN Director | Grant or award · Stock Option | +13,000 | 13,000 | ||
| 2018-09-27 | EASTHAM KARIN Director | Grant or award | +8,500 | 8,500 | ||
| 2018-09-27 | EASTHAM KARIN Director | Grant or award · Stock Option | +17,000 | 17,000 |
Page 1 of 1 · 13 trades